Seeing Is Believing
VIR is currently covered by 9 analysts with an average price target of $19.61. This is a potential upside of $9.51 (94.16%) from yesterday's end of day stock price of $10.1.
Vir Biotechnology's activity chart (see below) currently has 54 price targets and 61 ratings on display. The stock rating distribution of VIR is 67.86% BUY, 10.71% SELL and 21.43% HOLD.
Analysts average stock forecasts to be materialized ratio is 54.91% with an average time for these price targets to be met of 141.54 days.
Highest price target for VIR is $41, Lowest price target is $10, average price target is $19.61.
Most recent stock forecast was given by ERIC JOSEPH from JPMORGAN on 23-Feb-2024. First documented stock forecast 05-Nov-2019.
Currently out of the existing stock ratings of VIR, 19 are a BUY (67.86%), 3 are a SELL (10.71%), 6 are a HOLD (21.43%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
10
$-0.1 (-0.99%)
9
1 months 5 days ago
2/4 (50%)
$-1.53 (-13.27%)
15
Buy
1 months 14 days ago
1/7 (14.29%)
$76.91 (333.09%)
128
12
$1.9 (18.81%)
15
4 months 22 days ago
1/3 (33.33%)
$3.37 (39.05%)
3
Buy
15
$4.9 (48.51%)
22
4 months 25 days ago
0/9 (0%)
$6.24 (71.23%)
Hold
14
$3.9 (38.61%)
55
6 months 20 days ago
1/2 (50%)
$3 (27.27%)
113
What is VIR (Vir Biotechnology) average time for price targets to be met?
Which analyst has the current highest performing score on VIR (Vir Biotechnology) with a proven track record?
Which analyst has the most public recommendations on VIR (Vir Biotechnology)?
Which analyst is the currently most bullish on VIR (Vir Biotechnology)?
Which analyst is the currently most reserved on VIR (Vir Biotechnology)?